Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
Mayla Gabriela Silva Borba, Fernando Val, Vanderson de Souza Sampaio, et al.
JAMA Network Open (2020) Vol. 3, Iss. 4, pp. e208857-e208857
Open Access | Times Cited: 951

Showing 26-50 of 951 citing articles:

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2
Robert Landewé, Pedro Machado, Féline P B Kroon, et al.
Annals of the Rheumatic Diseases (2020) Vol. 79, Iss. 7, pp. 851-858
Open Access | Times Cited: 251
Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: a review of current evidence
Sayeeda Rahman, Maria Teresa Villagomez Montero, Kherie Rowe, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 5, pp. 601-621
Open Access | Times Cited: 250
SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy
Prasun K. Datta, Fengming Liu, Tracy Fischer, et al.
Theranostics (2020) Vol. 10, Iss. 16, pp. 7448-7464
Open Access | Times Cited: 239
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Peter Horby, Marion Mafham, Louise Linsell, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 239
The immunology of COVID-19: is immune modulation an option for treatment?
Jixin Zhong, Jungen Tang, Cong Ye, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 7, pp. e428-e436
Open Access | Times Cited: 237
Management of critically ill patients with COVID-19 in ICU: statement from front-line intensive care experts in Wuhan, China
You Shang, Chun Pan, Xianghong Yang, et al.
Annals of Intensive Care (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 235
‘An invisible human rights crisis’: The marginalization of older adults during the COVID-19 pandemic – An advocacy review
Migita D’cruz, Debanjan Banerjee
Psychiatry Research (2020) Vol. 292, pp. 113369-113369
Open Access | Times Cited: 222
Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19
Adrían V. Hernández, Yuani M. Roman, Vinay Pasupuleti, et al.
Annals of Internal Medicine (2020) Vol. 173, Iss. 4, pp. 287-296
Closed Access | Times Cited: 220
Diabetes is most important cause for mortality in COVID-19 hospitalized patients: Systematic review and meta-analysis
Giovanni Corona, Alessandro Pizzocaro, Walter Vena, et al.
Reviews in Endocrine and Metabolic Disorders (2021) Vol. 22, Iss. 2, pp. 275-296
Open Access | Times Cited: 210
Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim, Min Ho An, Won Jun Kim, et al.
PLoS Medicine (2020) Vol. 17, Iss. 12, pp. e1003501-e1003501
Open Access | Times Cited: 203
Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Yue-Ming Gao, Gang Xu, Bin Wang, et al.
Journal of Internal Medicine (2020) Vol. 289, Iss. 2, pp. 147-161
Open Access | Times Cited: 199
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19
Bhagteshwar Singh, Hannah Ryan, Tamara Kredo, et al.
Cochrane library (2021) Vol. 2021, Iss. 2
Open Access | Times Cited: 190
QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review
Lior Jankelson, Giorgio Karam, Matthijs L. Becker, et al.
Heart Rhythm (2020) Vol. 17, Iss. 9, pp. 1472-1479
Open Access | Times Cited: 185
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Awadhesh Kumar Singh, Akriti Singh, Ritu Singh, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2020) Vol. 14, Iss. 4, pp. 641-648
Open Access | Times Cited: 184
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2
Kathleen Chiotos, Molly Hayes, David W. Kimberlin, et al.
Journal of the Pediatric Infectious Diseases Society (2020) Vol. 9, Iss. 6, pp. 701-715
Open Access | Times Cited: 183
How COVID-19 has fundamentally changed clinical research in global health
Jay Park, Robin Mogg, Gerald E. Smith, et al.
The Lancet Global Health (2021) Vol. 9, Iss. 5, pp. e711-e720
Open Access | Times Cited: 175
Antibiotics in treatment of COVID-19 complications: a review of frequency, indications, and efficacy
Marie Chedid, Rami Waked, Élie Haddad, et al.
Journal of Infection and Public Health (2021) Vol. 14, Iss. 5, pp. 570-576
Open Access | Times Cited: 168
Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care
Susan Olender, Katherine K Perez, Alan S. Go, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 11, pp. e4166-e4174
Open Access | Times Cited: 166
COVID‐19 vaccine hesitancy and attitudes in Qatar: A national cross‐sectional survey of a migrant‐majority population
Majid Alabdulla, Shuja Reagu, Abdullatif Al‐Khal, et al.
Influenza and Other Respiratory Viruses (2021) Vol. 15, Iss. 3, pp. 361-370
Open Access | Times Cited: 156
Arrhythmias and COVID-19
Parinita Dherange, Joshua Lang, Pierre Qian, et al.
JACC. Clinical electrophysiology (2020) Vol. 6, Iss. 9, pp. 1193-1204
Open Access | Times Cited: 149
Methodological quality of COVID-19 clinical research
Richard G. Jung, Pietro Di Santo, Cole Clifford, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 147
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1059-1103
Open Access | Times Cited: 147
Pathogenesis of Multiple Organ Injury in COVID-19 and Potential Therapeutic Strategies
Miquéias Lopes‐Pacheco, Pedro Leme Silva, Fernanda F. Cruz, et al.
Frontiers in Physiology (2021) Vol. 12
Open Access | Times Cited: 146
New Insights of Emerging SARS-CoV-2: Epidemiology, Etiology, Clinical Features, Clinical Treatment, and Prevention
Gangqiang Guo, Lele Ye, Kan Pan, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 143
Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
Jennifer C. E. Lane, James Weaver, Kristin Kostka, et al.
The Lancet Rheumatology (2020) Vol. 2, Iss. 11, pp. e698-e711
Open Access | Times Cited: 143

Scroll to top